ABMD » Topics » (Registrants telephone number, including area code)

This excerpt taken from the ABMD 10-Q filed Feb 9, 2009.

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of January 30, 2009, there were 36,686,638 shares outstanding of the registrant’s Common Stock, $.01 par value.

 

 

 


Table of Contents
This excerpt taken from the ABMD 10-Q filed Nov 10, 2008.

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

  Large accelerated filer  ¨    Accelerated filer  x  
  Non-accelerated filer  ¨    Smaller reporting company  ¨  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of November 4, 2008, there were 36,594,652 shares outstanding of the registrant’s Common Stock, $.01 par value.

 

 

 


Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

This excerpt taken from the ABMD 10-Q filed Aug 11, 2008.

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨
(Do not check if a smaller reporting company)       

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of August 1, 2008, there were 33,730,765 shares outstanding of the registrant’s Common Stock, $.01 par value.

 

 


Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

          Page
PART I - FINANCIAL INFORMATION:   
Item 1.    Financial Statements    3
   Condensed Consolidated Balance Sheets as of June 30, 2008 (unaudited) and March 31, 2008    3
   Condensed Consolidated Statements of Operations for the three months ended June 30, 2008 and 2007 (unaudited)    4
   Condensed Consolidated Statements of Cash Flows for the three months ended June 31, 2008 and 2007 (unaudited)    5
   Notes to Condensed Consolidated Financial Statements (unaudited)    6
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations.    16
Item 3.    Quantitative and Qualitative Disclosures About Market Risk.    21
Item 4.    Controls and Procedures.    22
PART II - OTHER INFORMATION   
Item 1.    Legal Proceedings.    23
Item 1A.    Risk Factors.    23
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.    25
Item 3.    Defaults Upon Senior Securities.    25
Item 4.    Submission of Matters to a Vote of Security Holders.    25
Item 5.    Other Information.    25
Item 6.    Exhibits.    26
SIGNATURES    27

ABIOMED and ABIOCOR are trademarks of ABIOMED, Inc., and are registered in the United States and certain foreign countries. BVS is a trademark of ABIOMED, Inc. and is registered in the United States. AB5000 is a trademark of ABIOMED, Inc. IMPELLA and RECOVER are trademarks of Abiomed Europe GmbH, a subsidiary of ABIOMED, Inc., and are registered in the United States and certain foreign countries.

 

2


Table of Contents
This excerpt taken from the ABMD 10-Q filed Feb 11, 2008.

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of February 4, 2008, there were 32,626,330 shares outstanding of the registrant’s Common Stock, $.01 par value.

 

 

 


Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

          Page
PART I -FINANCIAL INFORMATION:   

Item 1.

  

Financial Statements

   3
  

Condensed Consolidated Balance Sheets as of December 31, 2007 (unaudited) and March 31, 2007

   3
  

Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2007 and 2006 (unaudited)

   4
  

Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2007 and 2006 (unaudited)

   5
  

Notes to Condensed Consolidated Financial Statements (unaudited)

   6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   18

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk.

   28

Item 4.

  

Controls and Procedures.

   29
PART II - OTHER INFORMATION   

Item 1.

  

Legal Proceedings.

   30

Item 1A.

  

Risk Factors.

   30

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds.

   31

Item 3.

  

Defaults Upon Senior Securities.

   31

Item 4.

  

Submission of Matters to a Vote of Security Holders.

   31

Item 5.

  

Other Information.

   31

Item 6.

  

Exhibits.

   31

SIGNATURES

   32

ABIOMED and ABIOCOR are trademarks of ABIOMED, Inc., and are registered in the United States and certain foreign countries. BVS is a trademark of ABIOMED, Inc. and is registered in the United States. AB5000 is a trademark of ABIOMED, Inc. IMPELLA and RECOVER are trademarks of Abiomed Europe GmbH, a subsidiary of ABIOMED, Inc., and are registered in the United States and certain foreign countries.

 

2


Table of Contents
This excerpt taken from the ABMD 10-Q filed Nov 8, 2007.

(Registrant’s telephone number, including area code)

 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of November 7, 2007, there were 32,523,761 shares outstanding of the registrant’s Common Stock, $.01 par value.

 



Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

     Page
  PART I -FINANCIAL INFORMATION:   
    Item 1.   Financial Statements    3
      Condensed Consolidated Balance Sheets as of September 30, 2007 (unaudited) and March 31, 2007    3
      Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2007 and 2006 (unaudited)    4
      Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2007 and 2006 (unaudited)    5
      Notes to Condensed Consolidated Financial Statements (unaudited)    6
    Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations.    16
    Item 3.   Quantitative and Qualitative Disclosures About Market Risk.    23
    Item 4.   Controls and Procedures.    24
  PART II - OTHER INFORMATION   
    Item 1.   Legal Proceedings.    25
    Item 1A.   Risk Factors.    25
    Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.    26
    Item 3.   Defaults Upon Senior Securities.    26
    Item 4.   Submission of Matters to a Vote of Security Holders.    26
    Item 5.   Other Information.    26
   

Item 6.

  Exhibits.    26
   

SIGNATURES

   27

ABIOMED and ABIOCOR are trademarks of ABIOMED, Inc., and are registered in the U.S.A. and certain foreign countries. BVS is a trademark of ABIOMED, Inc. and is registered in the U.S.A. AB5000 is a trademark of ABIOMED, Inc. IMPELLA and RECOVER are trademarks of Abiomed Europe GmbH, a subsidiary of ABIOMED, Inc., and are registered in the U.S.A. and certain foreign countries.

 

2


Table of Contents
This excerpt taken from the ABMD 10-Q filed Aug 9, 2007.

(Registrant’s telephone number, including area code)

 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of August 6, 2007, there were 32,469,819 shares outstanding of the registrant’s Common Stock, $.01 par value.

 



Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

This excerpt taken from the ABMD 10-Q filed Feb 8, 2007.

(Registrant’s telephone number, including area code)

 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of February 6, 2007, there were 26,766,455 shares outstanding of the registrant’s Common Stock, $.01 par value.

 



Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

           Page

PART I - FINANCIAL INFORMATION:

  

Item 1.

  Financial Statements    3
 

Condensed Consolidated Balance Sheets as of December 31, 2006 (unaudited) and March 31, 2006

   3
 

Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2006 and 2005 (unaudited)

   4
 

Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2006 and 2005 (unaudited)

   5
 

Notes to Condensed Consolidated Financial Statements (unaudited)

   6

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations.    18

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk.    26

Item 4.

  Controls and Procedures.    27

PART II- OTHER INFORMATION

   28

Item 1.

  Legal Proceedings.    28

Item 1A.

  Risk Factors.    28

Item 2.

  Unregistered Sales of Equity Securities and Use of Proceeds.    43

Item 3.

  Defaults Upon Senior Securities.    43

Item 4.

  Submission of Matters to a Vote of Security Holders.    43

Item 5.

  Other Information.    43

Item 6.

  Exhibits.    43

SIGNATURES

   46

 

2


Table of Contents

PART 1. FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

ABIOMED, INC. AND SUBSIDIARIES

This excerpt taken from the ABMD 10-Q filed Nov 8, 2006.

(Registrant’s telephone number, including area code)

 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of November 7, 2006, there were 26,703,249 shares outstanding of the registrant’s Common Stock, $.01 par value.

 



Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

     Page

PART I - FINANCIAL INFORMATION:

  

Item 1. Financial Statements

   3

Condensed Consolidated Balance Sheets as of September 30, 2006 and March 31, 2006

   3

Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2006 and 2005

   4

Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2006 and 2005

   5

Notes to Condensed Consolidated Financial Statements

   6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   19

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

   27

Item 4. Controls and Procedures.

   28

PART II- OTHER INFORMATION

   29

Item 1. Legal Proceedings.

   29

Item 1A. Risk Factors.

   29

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

   29

Item 3. Defaults Upon Senior Securities.

   29

Item 4. Submission of Matters to a Vote of Security Holders.

   29

Item 5. Other Information.

   29

Item 6. Exhibits.

   29

SIGNATURES

   33

 

2


Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

PART 1. FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

This excerpt taken from the ABMD 10-Q filed Aug 9, 2006.

(Registrant’s telephone number, including area code)

 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is, a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definitions of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨    Accelerated Filer  x    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of August 7, 2006, there were 26,565,191 shares outstanding of the registrant’s Common Stock, $.01 par value.

 



Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

     Page No.

PART I - FINANCIAL INFORMATION:

   3

Item 1. Condensed Consolidated Financial Statements (unaudited).

   3

Condensed Consolidated Balance Sheets as of June 30, 2006 and March 31, 2006

   3

Condensed Consolidated Statements of Operations for the Three Months Ended June 30, 2006 and 2005

   4

Condensed Consolidated Statements of Cash Flows for the Three Months Ended June 30, 2006 and 2005

   5

Notes to Condensed Consolidated Financial Statements

   6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   18

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

   25

Item 4. Controls and Procedures.

   26

PART II - OTHER INFORMATION

   27

Signature

   27

 

2


Table of Contents

ABIOMED, INC. AND SUBSIDIARIES

PART 1. FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki